Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Sirona Biochem Corp.
  6. News
  7. All News
    SBM   CA82967M1005

SIRONA BIOCHEM CORP.

(SBM)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about SIRONA BIOCHEM CORP.
09/22SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Discovery of Anti-Cellulite Activ..
AQ
09/22SIRONA BIOCHEM : Details Discovery of Anti-Cellulite Activity in Compounds
MT
09/22SIRONA BIOCHEM : Announces Discovery of Anti-Cellulite Activity in Compounds
AQ
09/22Sirona Biochem Corp. Announces Discovery of Anti-Cellulite Activity in Compounds
CI
06/30SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/
AQ
06/30SIRONA BIOCHEM : CEO Quarterly Update Q2 2021
AQ
06/29Sirona Biochem Corp. Reports Earnings Results for the Second Quarter Ended April 30, 20..
CI
03/31SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical S..
AQ
03/31SIRONA BIOCHEM : Reports "Excellent Results" in New Clinical Study on TFC-1067
MT
03/31SIRONA BIOCHEM : Reports Excellent Results in New Clinical Study on TFC-1067
AQ
03/31Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067
CI
03/10SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Launch of First Commercial Produc..
AQ
03/10SIRONA BIOCHEM : Says First Commercial Product Containing TFC-1067 Compound to be Launched
MT
03/10SIRONA BIOCHEM : Announces Launch of First Commercial Product Containing TFC-1067
AQ
03/10Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067
CI
03/03Sirona Biochem Corp. Auditor Raises 'Going Concern' Doubt
CI
03/03Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October 31, 2020
CI
02/24SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/
AQ
02/24SIRONA BIOCHEM : CEO Quarterly Update Q1 2021
AQ
02/03SIRONA BIOCHEM : Announces Grant of Stock Options
AQ
2020Sirona Biochem Corp. Signs Agreement with Luxembourg-based CURE Intelligence for Social..
CI
2020SIRONA BIOCHEM : Signs Agreement with Luxembourg-based CURE Intelligence for Social Media ..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Releases CEO Letter to Shareholders/
AQ
2020SIRONA BIOCHEM : Releases CEO Letter to Shareholders
AQ
2020SIRONA BIOCHEM : Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cos..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Announces Acceptance of Clinical Study for ..
AQ
2020SIRONA BIOCHEM : Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cos..
AQ
2020Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Co..
CI
2020SIRONA BIOCHEM : Signs Agreement with Global Pharmaceutical Company for Clinical Trial of ..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Signs Agreement with Global Pharmaceutical ..
AQ
2020SIRONA BIOCHEM : Signs Agreement with Global Pharmaceutical Company for Clinical Trial of ..
AQ
2020Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of..
CI
2020Sirona Biochem Corp. Reports Earnings Results for the Third Quarter Ended July 31, 2020
CI
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Contracts WuXi AppTec for Large-Scale Manuf..
AQ
2020Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
CI
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020Sirona Biochem Corp. Reports Earnings Results for the Second Quarter Ended April 30, 20..
CI
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fi..
AQ
2020SIRONA BIOCHEM : Ships First Batch of TFC-1067 to Rodan + Fields
AQ
2020Sirona Biochem Corp. Ships First Batch of TFC-1067 to Rodan + Fields
CI
2020SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the D..
AQ
2020/R E P E A T -- SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-G..
AQ
2020SIRONA BIOCHEM : Interview with Chief Scientific Officer Dr. Deliencourt-Godefroy on the D..
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Initiates COVID-19 and Infectious Diseases ..
AQ
2020SIRONA BIOCHEM : Initiates COVID-19 and Infectious Diseases Development Program
AQ
2020Sirona Biochem Corp. Reports Earnings Results for the First Quarter Ended January 31, 2..
CI
2020SIRONA BIOCHEM : Letter to the Shareholders
AQ
2020/R E P E A T -- SIRONA BIOCHEM : Letter to the Shareholders/
AQ
2020SIRONA BIOCHEM : Letter to the Shareholders
AQ
2020SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Signs Letter of Intent with Top Chinese Pha..
AQ
2020SIRONA BIOCHEM : Signs Letter of Intent with Top Chinese Pharmaceutical Development Compan..
AQ
2020Sirona Biochem Corp. Signs Letter of Intent with Beijing Huaxi Pharma Co, Ltd
CI
2020Sirona Biochem Corp. Auditor Raises 'Going Concern' Doubt
CI
2020Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October 31, 2019
CI
2020SIRONA BIOCHEM : Announces Change of Auditor
AQ
2020SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentration of TFC-1067
AQ
2020/R E P E A T -- SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentratio..
AQ
2020SIRONA BIOCHEM : 100% Safety in Final Tox Study for Increased Concentration of TFC-1067
AQ
2020Sirona Biochem Corp. Completes Final Toxicology Test, a Human Repeated Insult Patch Tes..
CI
2020SIRONA BIOCHEM : Announces Grant of Stock Options
AQ
2019SIRONA BIOCHEM : R E P E A T -- Sirona Biochem CEO Letter to Shareholders/
AQ
2019SIRONA BIOCHEM : CEO Letter to Shareholders
AQ
2019SIRONA BIOCHEM : R E P E A T -- Sirona Biochem Reports 100% Safety in First Tox Study for ..
AQ
2019SIRONA BIOCHEM : Reports 100% Safety in First Tox Study for Increased Concentration of TFC..
AQ
2019Sirona Biochem Corp. Reports 100% Safety in First Tox Study for Increased Concentration..
CI
2019Sirona Biochem Proceeds to First Clinical Tests for Higher Concentrations to Increase C..
CI
2019Sirona Biochem Corp. to Sign Agreement with Rodan + Fields at Cosmetic 360 Conference i..
CI
2019Sirona Biochem Corp. Reports Earnings Results for the Third Quarter Ended July 31, 2019
CI
2019Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leade..
CI
2019Sirona Biochem Corp. announced that it has received CAD 1.5 million in funding
CI
2019Sirona Biochem Corp. announced that it expects to receive CAD 1 million in funding
CI
2019Sirona Biochem Corp. Announces SGLT2 Inhibitor Development Progress
CI
2019Sirona Biochem Signs Term Sheet for TFC-1067 with Skincare Industry Leader Rodan + Fiel..
CI
2019Sirona Biochem Announces TFC-1067 Skin Lightening Patent Granted in USA
CI
1  2Next
Upcoming event on SIRONA BIOCHEM CORP.
10/05/21